Value
5.3/10data confidence 83%| Component | Sub-score |
|---|---|
| P/E | 4.2 |
| P/S | 3.8 |
| Fwd P/E | 4.6 |
| PEG | 6.5 |
| Analyst target | 7.5 |
- ▸Forward P/E: 26.8x
- ▸PEG: 1.13
ARGX · Why this verdict
Why argenx (ARGX) is rated BUY WAIT
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictBUY WAIT
Overall score7.0/10
ConfidenceHIGH
MacroRISK_OFF
TrendMatrix Research · core thesis
Engine thesis — one sentence
This healthcare franchise combines a perfect four-quarter earnings beat streak averaging 23.2% positive surprise, 63% revenue growth, a maximum Piotroski financial health score, and a golden-cross technical breakout — one of the highest-quality growth setups in the universe — though the 5.1% upside at the current spot price creates an asymmetry gap that favors waiting for a pullback near the $812.92 entry target.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Business quality scores 9.0 out of 10, supported by a maximum (9 out of 9) Piotroski financial health score, 31% gross margins, and strong operating and net margins — the hallmarks of a financially healthy franchise. Quality | Gross margin remains above 28% and the Piotroski score stays at 8 or above for the next two annual reports. | ↑Improving |
| CounterA forward P/E of 24.0x and PEG of 1.48 price in strong near-term growth continuation; if margin expansion stalls, the premium multiple could compress, negating much of the quality benefit for holders who pay today's price. | ||
The company has beaten consensus earnings estimates in all four reported quarters with an average positive surprise of 23.2%, demonstrating a sustained pattern of under-promising and over-delivering that tends to support premium multiples. Catalyst | Earnings beats continue for the next two quarterly reports with an average positive surprise above 10%. | ↓Deteriorating |
| CounterDespite the perfect beat record, OBV has been falling — signaling institutional distribution on price strength — and implied volatility at 67% means the options market is pricing in an outsized move at the next earnings print, which cuts both ways. | ||
Revenue grew 63% year-over-year, the highest growth rank in the scorecard, positioning the company to sustain or grow into a premium multiple if the expansion trajectory continues for several more quarters. Growth | Revenue growth sustains above 30% year-over-year for the next two consecutive quarters. | →Stable |
| CounterGrowth at this pace naturally invites competitive responses, and falling OBV suggests the market may already be de-rating the stock on expectations of natural deceleration — a pattern where the fastest-growing periods can also mark the peak of valuation expansion. | ||
A golden cross has formed with the stock above all major moving averages, RSI at 66, and MACD in a bullish configuration — a technically strong setup associated with continuation moves in quality growth names. Momentum | The stock holds above the 200-day moving average for two consecutive months and MACD remains in a positive crossover configuration. | ↓Deteriorating |
| CounterDespite the golden cross, volume is distributing rather than accumulating (falling OBV), which can precede a failed breakout; implied volatility at 67% means the next catalyst event carries substantial two-directional risk. | ||
At the current price, only 5.1% of upside remains to the near-term resistance target of $928.90; the suggested entry near $812.92 would restore a more favorable risk/reward of roughly 1.6-to-1 and represents a disciplined starting point for an initial position. Engine gate (failed) | The stock pulls back within 8% of the $812.92 entry level within the next quarter, offering improved asymmetry for a first tranche. | ↑Improving |
| CounterThe golden cross is already confirmed and momentum scores above the strong threshold — the stock may not offer a meaningful pullback toward $812, meaning strict entry discipline risks missing a high-quality name that continues its breakout. | ||
Business quality scores 9.0 out of 10, supported by a maximum (9 out of 9) Piotroski financial health score, 31% gross margins, and strong operating and net margins — the hallmarks of a financially healthy franchise.
↑ImprovingQuality
- Expectation
- Gross margin remains above 28% and the Piotroski score stays at 8 or above for the next two annual reports.
CounterA forward P/E of 24.0x and PEG of 1.48 price in strong near-term growth continuation; if margin expansion stalls, the premium multiple could compress, negating much of the quality benefit for holders who pay today's price.
The company has beaten consensus earnings estimates in all four reported quarters with an average positive surprise of 23.2%, demonstrating a sustained pattern of under-promising and over-delivering that tends to support premium multiples.
↓DeterioratingCatalyst
- Expectation
- Earnings beats continue for the next two quarterly reports with an average positive surprise above 10%.
CounterDespite the perfect beat record, OBV has been falling — signaling institutional distribution on price strength — and implied volatility at 67% means the options market is pricing in an outsized move at the next earnings print, which cuts both ways.
Revenue grew 63% year-over-year, the highest growth rank in the scorecard, positioning the company to sustain or grow into a premium multiple if the expansion trajectory continues for several more quarters.
→StableGrowth
- Expectation
- Revenue growth sustains above 30% year-over-year for the next two consecutive quarters.
CounterGrowth at this pace naturally invites competitive responses, and falling OBV suggests the market may already be de-rating the stock on expectations of natural deceleration — a pattern where the fastest-growing periods can also mark the peak of valuation expansion.
A golden cross has formed with the stock above all major moving averages, RSI at 66, and MACD in a bullish configuration — a technically strong setup associated with continuation moves in quality growth names.
↓DeterioratingMomentum
- Expectation
- The stock holds above the 200-day moving average for two consecutive months and MACD remains in a positive crossover configuration.
CounterDespite the golden cross, volume is distributing rather than accumulating (falling OBV), which can precede a failed breakout; implied volatility at 67% means the next catalyst event carries substantial two-directional risk.
At the current price, only 5.1% of upside remains to the near-term resistance target of $928.90; the suggested entry near $812.92 would restore a more favorable risk/reward of roughly 1.6-to-1 and represents a disciplined starting point for an initial position.
↑ImprovingEngine gate (failed)
- Expectation
- The stock pulls back within 8% of the $812.92 entry level within the next quarter, offering improved asymmetry for a first tranche.
CounterThe golden cross is already confirmed and momentum scores above the strong threshold — the stock may not offer a meaningful pullback toward $812, meaning strict entry discipline risks missing a high-quality name that continues its breakout.
Per-dimension breakdown
Quality
9.2/10data confidence 71%| Component | Sub-score |
|---|---|
| Gross margin | 8.0 |
| Op margin | 10.0 |
| Net margin | 10.0 |
| Moat | 8.0 |
| Piotroski F | 10.0 |
- ▸Strong margins: 32%
- ▸Wide economic moat
- ▸Strong Piotroski F-Score: 9/9
- ▸High-quality business
Growth
10.0/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 10.0 |
| EPS growth | 10.0 |
- ▸Strong growth: 52% YoY
Momentum
4.6/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 5.0 |
| MACD | 10.0 |
| OBV | 1.0 |
| MA position | 7.0 |
| Volume | 0.0 |
- ▸Volume distribution (falling OBV)
- ▸Above 200-day MA
Sentiment
7.3/10data confidence 100%| Component | Sub-score |
|---|---|
| LLM sentiment | 6.0 |
| Analyst rating | 7.5 |
| Price target | 8.5 |
- ▸Analyst upside: 29%
Insider
5.0/10data confidence 50%Peer rank
7.0/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 4.4 |
| quality rank | 7.9 |
| growth rank | 7.3 |
- ▸Conservative debt levels
Technical
5.2/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 3.6 |
| support resistance | 4.4 |
| 52w position | 6.6 |
| gap | 6.0 |
Risk (lower is worse)
6.5/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 8.9 |
| days to cover | 7.4 |
| volatility | 4.4 |
| put call | 5.1 |
| implied vol | 6.5 |
| max pain risk | 3.0 |
| debt equity | 10.0 |
- ▸Above max pain $340
Catalyst
7.4/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
| news activity | 7.0 |
- ▸Perfect beat streak: 4Q
How the verdict was assembled
Engine trigger
Growth is cheap relative to earnings, but the technical setup has not yet produced a breakout above resistance (PEG 1.13, quality 9.2/10, growth 10.0/10).
Engine technical detail
verdict_path:
L4:PATH_C2_GARP_WAIT|ENTRY_STICKY:WITHIN_BANDPassed (7)
- MOMENTUM:4.6>=4.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:119d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:1.4<1.5@spot
Warning (1)
- MOMENTUM:4.6<5.5 (soft — BUY_NOW allowed but watch)
Reward-to-Risk
1.35
Upside
+15.8%
Downside
11.7%
Sizing output
STARTER
Setup— — No clear chart pattern; technical signals are mixed
EdgeNo clear edge — No clear edge identified
SuitabilitySpeculative — Binary industry: Biotechnology
Investment implication
The C-path quality+growth combination triggered the STRONG_BUY_WAIT verdict: quality 9.2 and growth 10.0 both clear their thresholds, with asymmetric R:R of 1.35 supporting the read.
The strongest dimensions are Growth at 10.0, Quality at 9.2, and Catalyst at 7.4; the weakest are Momentum at 4.6, Insider at 5.0, and Technical at 5.2. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of 1.35 and an engine sizing output of STARTER.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Perfect Four Quarter Beat Streak
Trip ifEPS surprise falls below 0% for any single quarter, ending the perfect beat streak.
- P2Exceptional Business Quality
Trip ifGross margin compresses below 25% from current 31% for 2 consecutive quarters.
- P3Sixty Three Percent Revenue Growth
Trip ifRevenue growth falls below 20% YoY for 2 consecutive quarters.
- P4Golden Cross Breakout Momentum
Trip ifStock closes below the 200-day moving average for 2 consecutive weeks.
- P5Spot Upside Gap Favors Entry Discipline
Trip ifStock price closes above $950.00, exceeding the $928.90 target and making the entry-discipline framework obsolete.